$100K — $150K *
The Sr. Clinical Trial Manager (Sr. CTM) will be responsible for the operational management and oversight of Faraday's upcoming phase 3 study in the treatment of acute ST-Elevation Myocardial Infarction (STEMI) and reperfusion injury.
The Sr. CTM will work closely with the Medical Monitor and other cross-functional representatives within both Faraday Pharmaceuticals and designated CROs, including Data Management, Biostatistics, Regulatory, Quality Assurance to ensure successful completion of all clinical activities and project deliverables within the required time frame and budget. The Sr. CTM will also provide oversight of the CRO and other third-party vendors.
Valid through: 7/16/2020
$180K — $225K + $120 hourly